Recruiting
Phase 2
Phase 3

DDP733

Sponsor:

Dynogen Pharmaceuticals

Code:

NCT00547469

Conditions

Irritable Bowel Syndrome

Eligibility Criteria

Sex: Female

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

DDP733

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-21. This information was provided to ClinicalTrials.gov by Dynogen Pharmaceuticals on 2008-04-08.